RA patients also had a lower relative expression of CD81/CD9 double positive anti-CD81 captured sEVs than healthy controls, but for this sEV population the differences were only significant between the post-MTX groups and healthy controls (p = 0.04) (Fig. 4b). This evidence concerns the gene CD9 and rheumatoid arthritis.